MedTest DX Introduces a Highly Complex Drug of Abuse Test Menu

MedTest DX, A MedTest Company, is pleased to announce the introduction of a broad, highly complex drug of abuse menu for the MindrayTM BS- 200 Chemistry Analyzer, the Poly-Chem® 180 Analyzer and as open channel applications on other clinical chemistry analyzers such as the Beckman Coulter AU instrument series in the United States. The introduction of this menu enables MedTest DX to provide high quality drug of abuse reagents to customers focused on pain management and drug abuse testing.

MindrayTM BS-200 and Open Channel Applications
MedTest DX introduces 16 highly complex, urine drugs of abuse tests that include: 6-Acetylmorphine, Amphetamine, Barbiturate, Benzodiazepine, Buprenorphine (Suboxone), Cannabinoid (THC), Cocaine Metabolite, Ecstasy (MDMA), Ethanol, Methadone, Methadone Metabolite (EDDP), Methamphetamine, Opiates, Oxycodone, Phencyclidine and Propoxyphene.

Poly-Chem® 180
MedTest DX introduces 5 highly complex, urine drugs of abuse tests (6-Acetylmorphine, Buprenorphine, Oxycodone, Phencyclidine and Propoxyphene) to its existing 10 tests that make up the moderately complex test menu.

"Menu expansion enables MedTest DX to meet our customer's needs in the pain management and drug abuse testing arena" said Hanjoon Ryu, CEO of MedTest. "Our drugs of abuse offering on analyzers like the MindrayTM BS-200 enable our pain management clinic customers to implement a quality urine screening process while allowing our laboratory customers to minimize their overall cost and enhance their overall efficiency."